Lukas Schüpbach to head up Chr. Hansen and Lonza biotherapeutic firm Bacthera 10-Jan-2020 By Will Chu Bacthera, the joint venture between Chr. Hansen and Lonza looking into Live Biotherapeutic Products (LBP), announces Lukas Schüpbach as the company’s new CEO.